查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1433324

2023-2030 年全球全切片影像市場

Global Whole Slide Imaging Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

預計在預測期內（2023-2030 年），全球全切片影像市場將以 6.4% 的CAGR成長。該市場的成長歸因於全球電腦處理能力的增強。功能強大的電腦的發展使得處理和分析 WSI 掃描器產生的大量影像成為可能。由於技術的進步，影像分析變得更加快速和精確。據美國國立衛生研究院 (gov.) 稱，2023 年 7 月，病理學家、病理部門和研究科學家對全切片影像的使用有所增加。 2018 年和 2020 年進行的一項調查發現，無論是否使用傳統玻片，病理學家進行初步診斷的舒適度分別從 54% 增加到 90%，從 23% 增加到 60%。這很大程度上歸功於技術的進步，包括最先進的光學和機器人技術、電腦處理能力、資料傳輸速度、軟體開發和雲端儲存解決方案的提高。因此，WSI 已用於遠端病理學、諮詢、腫瘤板、玻片存檔以及與多種免疫組織化學染色的比較。

區隔市場前景

全球全切片影像市場依技術、應用和最終用戶進行區隔。根據技術，市場區隔為掃描器、IT 基礎設施和檢視器影像管理系統。根據應用，市場區隔為遠端病理學、細胞病理學、免疫組織化學、血液病理學等。此外，根據最終用戶，市場區隔為學術機構、醫院和醫療機構、藥物研究和合約研究組織（CRO）等。細胞病理學子類別預計將佔據應用領域的很大一部分市場佔有率。不斷增加的人口基數容易罹患多種疾病。細胞病理學是一種專門的診斷程序，透過檢查從組織中取出的單一細胞來確定疾病的來源和性質。

預計掃描器區隔市場將在全球全切片影像市場中佔據相當大的佔有率

在這些技術中，掃描器區隔市場預計將在全球全切片影像市場中佔據相當大的佔有率。此區隔市場的成長歸因於全球數位病理學需求的增加。對數位病理學解決方案的需求不斷增加，遠端存取幻燈片、遠端病理學和協作分析只是數位病理學優勢的一部分。病理學家和研究人員可以透過使用 NanoZoomer S20MD 等掃描儀從數位病理學中受益。例如，2023 年3 月，Hamamatsu Photonics 發布了新型NanoZoomer S20MD 載玻片掃描器系統(C16300-21MDEU)。NanoZoomer S20MD 載玻片掃描器系統提供卓越的影像品質和快速的吞吐量，可在15 分鐘內掃描20 張載玻片。它採用與高階型號相同的像素路徑設計，並包括影像擷取和檢視軟體。它也符合 IVDR（歐盟）、UKCA（英國）和 IvDO（瑞士）法規。

區域展望

全球全切片影像市場根據地理位置進一步區隔，包括北美（美國和加拿大）、歐洲（英國、義大利、西班牙、德國、法國和歐洲其他地區）、亞太地區（印度、中國、日本、韓國和亞洲其他地區）以及世界其他地區（中東和非洲以及拉丁美洲）。其中，由於人們對全切片影像優勢的認知不斷提高，加上印度和中國等一些國家人口基數廣泛，預計亞太地區將在全球市場中佔據顯著佔有率。以促進該地區的市場成長。

北美地區預計全球全切片影像市場複合CAGR顯著成長

在所有地區中，北美地區預計在預測期內將以相當大的CAGR成長。區域成長歸因於全球遠端病理學和遠端細胞學的發展。該研究在遠距細胞學評估中成功達到高靈敏度和特異性，並強調了遠距病理學在醫療保健改善中的重要性。涉及遠端細胞學的遠端病理學使病理學家能夠遠端存取和解釋數位切片，從而更容易提供診斷和諮詢，特別是在缺乏專業知識的領域。據MDPI 稱，2023 年10 月，這項前瞻性研究分析了LungenClinic Grosshansdorf 對239 名患者進行的314 項快速遠端線上細胞學評估（154 項印記細胞學檢查、143 項細針穿刺細胞學檢查和17項刷細胞學檢查）。在透過遠端細胞學進行現場評估期間，記錄了時間要求，並將結果與細胞/組織學和最終診斷進行比較。結果顯示，細胞學良性86例，惡性190例，不明診斷38例。排除診斷不明確的37例標本，最終診斷的敏感度為90.5%，特異度為98.5%，分類正確率為92.4%。細針穿刺對惡性腫瘤細胞學檢測的敏感率為76.1%，排除37例不明原因的檢體後，敏感率為92.5%。

市場參與者展望

服務於全切片影像市場的主要公司包括 Leica Microsystems GmbH、Olympus Corp. Philips International BV、NIKON CORP.、Visiopharm A/S 等。市場參與者透過各種策略（包括併購、合作、合作、融資和新產品發布），為市場成長做出了巨大貢獻，以保持市場競爭力。例如，2022 年 9 月，Infinitt 與 Hamamatsu 合作，改進了與 NanoZoomers 的整合，使實驗室和病理學家能夠在端到端操作工作流程中審查玻片。此外，IDPS 與 LIS 的整合將使病理學家能夠在數位環境中更有效率地工作。

報告涵蓋：

  • 2022年市場價​​值資料分析及2030年預測。
  • 每個區隔市場的年化市場收入（百萬美元）。
  • 主要地理區域的國家分析。
  • 全球全切片影像市場的主要公司。根據現有資料，報告中還提供了與新產品發布相關的資訊以及相關新聞。
  • 透過確定未來強勁成長的關鍵區隔市場來分析業務策略。
  • 市場進入和市場擴張策略分析。透過識別市場中「誰的立場」來制定競爭策略。

目錄

第 1 章：報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 依區隔
    • 依地區

第 2 章：市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第 3 章：競爭格局

  • 主要公司分析
  • 3DHISTECH Ltd.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Aiforia Technologies Oyj
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Akoya Biosciences, Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第 2 章：市場區隔

  • 依技術分類的全球全切片影像市場
    • 掃描儀
    • IT基礎架構
    • 瀏覽器圖像管理系統
  • 依應用分類的全球全切片影像市場
    • 遠端病理學
    • 細胞病理學
    • 免疫組織化學
    • 血液病理學
    • 其他（神經病理學、法醫病理學）
  • 依最終用戶分類的全球全切片影像市場
    • 有刷微電機
    • 無刷微電機
  • 依最終用戶分類的全球全切片影像市場
    • 學術機構
    • 醫院及醫療機構
    • 藥物研究和合約研究組織 (CRO)
    • 其他（生物技術和製藥公司以及政府衛生機構）

第 3 章：區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第 4 章：公司簡介

  • CureMetrix, Inc.
  • Flagship Biosciences, Inc.
  • HAMAMATSU Group
  • Huron Digital Pathology
  • Indica Labs, Inc.
  • Leica Microsystems GmbH
  • MBF Bioscience
  • Mikroscan Technologies
  • Molecular Machines & Industries GmbH
  • NIKON CORP.
  • Olympus Corp.
  • OPAL KELLY INC.
  • OptraSCAN Inc.
  • PerkinElmer AES
  • Philips International B.V.
  • Visiopharm A/S
  • Zeiss AG
Product Code: OMR2027993

Global Whole Slide Imaging Market Size, Share & Trends Analysis Report by Technology (Scanners, IT Infrastructure, and ViewerImage Management System), by Application (Telepathology, Cytopathology, Immunohistochemistry, Hematopathology, and Others), and by End-User (Academic Institute, Hospitals and Healthcare Institutions, Pharmaceutical Research and Contract Research Organizations (CROs), and Others), Forecast Period (2023-2030)

The global whole slide imaging market is anticipated to grow at a CAGR of 6.4% during the forecast period (2023-2030). The market's growth is attributed to the increased computer processing power across the globe. The development of powerful computers has made it possible to process and analyze enormous images generated by WSI scanners. Image analysis has grown more rapid and precise as a result of technology. According to the National Institute of Health (gov.), in July 2023, the use of whole slide imaging has increased among pathologists, pathology departments, and research scientists. A survey conducted in 2018 and 2020 found that the comfort of pathologists to make a primary diagnosis with or without access to traditional glass slides increased from 54% to 90%, and from 23% to 60%, respectively. This is largely attributed to advancements in technology, including state-of-the-art optics and robotics, increased computer processing power, data transfer speeds, software development, and cloud storage solutions. As such, WSI has been used for telepathology, consultation, tumor boards, archiving slides, and comparisons with multiple immunohistochemical staining.

Segmental Outlook

The global whole slide imaging market is segmented on the technology, application, and end-user. Based on the technology, the market is sub-segmented into scanners, it infrastructure, and viewer image management system. Based on the application, the market is sub-segmented into telepathology, cytopathology, immunohistochemistry, hematopathology, and others. Furthermore, on the basis of end-user, the market is sub-segmented into academic institute, hospitals and healthcare institutions, pharmaceutical research and contract research organizations (CROs), and others. The cytopathology subcategory is expected to capture a significant portion of the market share within the application segment. The increasing population base prone to numerous diseases. Cytopathology is a specialized diagnostic procedure that examines individual cells removed from tissues to determine the source and nature of a disease.

The Scanners Sub-Segment is Anticipated to Hold a Considerable Share of the Global Whole Slide Imaging Market

Among the technology, the scanners sub-segment is expected to hold a considerable share of the global whole slide imaging market. The segmental growth is attributed to the increased demand for digital pathology across the globe. Increase in demand for digital pathology solutions remote access to slides, telepathology, and collaborative analysis are merely a few of the advantages of digital pathology. Pathologists and researchers can benefit from digital pathology by utilizing scanners such as the NanoZoomer S20MD. For instance, in March 2023, Hamamatsu Photonics, released the new NanoZoomer S20MD Slide scanner system (C16300-21MDEU).The NanoZoomer S20MD Slide scanner system offers excellent image quality and rapid throughput, scanning 20 slides in 15 minutes. It is designed with the same pixel pathway as the high-end model and includes image acquisition and viewing software. It is additionally compliant with IVDR (EU), UKCA (UK) and IvDO (CH) regulations.

Regional Outlook

The global whole slide imaging market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to rising awareness of the benefits of whole slide imaging, in addition to an extensive population base in some countries such as India and China, have contributed to the region's market growth.

The North America Region is Expected to Grow at a Significant CAGR in the Global Whole Slide Imaging Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the telepathology and tele-cytology development across the globe. The study's success in reaching high sensitivity and specificity rates in remote cytological evaluations emphasizes the significance of telepathology in healthcare improvement. Telepathology, that involve tele-cytology, enables pathologists to remotely access and interpret digital slides, making it easier to provide diagnosis and consultations, particularly in areas where specialist expertise is scarce. According to the MDPI, in October 2023, the prospective study analyzed 314 Rapid Remote Online Cytological Evaluations (154 imprint cytologies, 143 fine needle aspirations and 17 brush cytologies) performed on 239 patients at the LungenClinic Grosshansdorf. During on-site evaluation via tele-cytology, the time requirement was recorded and the findings were compared with the cyto-/histological and final diagnoses. The results showed that 86 cytological benign, 190 malignant and 38 unclear diagnoses were recorded. Excluding the 37 specimens with unclear diagnoses, the sensitivity rate was 90.5%, the specificity rate was 98.5% and the correct classification rate was 92.4% with regard to the final diagnosis. The sensitivity rate for the cytological detection of malignant tumors was 76.1% for fine-needle aspirations and 92.5% when excluding the 37 specimens with unclear findings.

Market Players Outlook

The major companies serving the whole slide imaging market include Leica Microsystems GmbH, Olympus Corp. Philips International B.V., NIKON CORP., Visiopharm A/S, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in September 2022, Infinitt collaborated with Hamamatsu, offered improved integration with NanoZoomers, allowing laboratories and pathologists to review slides in an end-to-end operational workflow. Furthermore, the integration of IDPS with LIS will allow pathologists to work more efficiently in a digital environment.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global whole slide imaging market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies. Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. 3DHISTECH Ltd.
    • 1.1.1. Overview
    • 1.1.2. Financial Analysis
    • 1.1.3. SWOT Analysis
    • 1.1.4. Recent Developments
  • 3.3. Aiforia Technologies Oyj
    • 1.1.5. Overview
    • 1.1.6. Financial Analysis
    • 1.1.7. SWOT Analysis
    • 1.1.8. Recent Developments
  • 3.4. Akoya Biosciences, Inc.
    • 1.1.9. Overview
    • 1.1.10. Financial Analysis
    • 1.1.11. SWOT Analysis
    • 1.1.12. Recent Developments
  • 1.2. Key Strategy Analysis

2. Market Segmentation

  • 2.1. Global Whole Slide Imaging Market by Technology
    • 2.1.1. Scanners
    • 2.1.2. IT Infrastructure
    • 2.1.3. ViewerImage Management System
  • 2.2. Global Whole Slide Imaging Market by Application
    • 2.2.1. Telepathology
    • 2.2.2. Cytopathology
    • 2.2.3. Immunohistochemistry
    • 2.2.4. Hematopathology
    • 2.2.5. Others(Neuropathology, and Forensic Pathology)
  • 2.3. Global Whole Slide Imaging Market by End User
    • 2.3.1. Brushed Micromotor
    • 2.3.2. Brushless Micromotor
  • 2.4. Global Whole Slide Imaging Market by End-User
    • 2.4.1. Academic Institute
    • 2.4.2. Hospitals and Healthcare Institutions
    • 2.4.3. Pharmaceutical Research and Contract Research Organizations (CROs)
    • 2.4.4. Others(Biotechnology and Pharmaceutical Companies, and Government Health Agencies)

3. Regional Analysis

  • 3.1. North America
    • 3.1.1. United States
    • 3.1.2. Canada
  • 3.2. Europe
    • 3.2.1. UK
    • 3.2.2. Germany
    • 3.2.3. Italy
    • 3.2.4. Spain
    • 3.2.5. France
    • 3.2.6. Rest of Europe
  • 3.3. Asia-Pacific
    • 3.3.1. China
    • 3.3.2. India
    • 3.3.3. Japan
    • 3.3.4. South Korea
    • 3.3.5. Rest of Asia-Pacific
  • 3.4. Rest of the World

4. Company Profiles

  • 4.1. CureMetrix, Inc.
  • 4.2. Flagship Biosciences, Inc.
  • 4.3. HAMAMATSU Group
  • 4.4. Huron Digital Pathology
  • 4.5. Indica Labs, Inc.
  • 4.6. Leica Microsystems GmbH
  • 4.7. MBF Bioscience
  • 4.8. Mikroscan Technologies
  • 4.9. Molecular Machines & Industries GmbH
  • 4.10. NIKON CORP.
  • 4.11. Olympus Corp.
  • 4.12. OPAL KELLY INC.
  • 4.13. OptraSCAN Inc.
  • 4.14. PerkinElmer AES
  • 4.15. Philips International B.V.
  • 4.16. Visiopharm A/S
  • 4.17. Zeiss AG

LIST OF TABLES

  • 1. GLOBAL WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 2. GLOBAL WHOLE SLIDE IMAGING BY SCANNERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL WHOLE SLIDE IMAGING BY IT INFRASTRUCTURE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL WHOLE SLIDE IMAGING BY VIEWERIMAGE MANAGEMENT SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 6. GLOBAL WHOLE SLIDE IMAGING IN TELEPATHOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL WHOLE SLIDE IMAGING IN CYTOPATHOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL WHOLE SLIDE IMAGING IN IMMUNOHISTOCHEMISTRY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL WHOLE SLIDE IMAGING IN HEMATOPATHOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL WHOLE SLIDE IMAGING IN OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 12. GLOBAL WHOLE SLIDE IMAGING FOR ACADEMIC INSTITUTE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL WHOLE SLIDE IMAGING FOR HOSPITALS AND HEALTHCARE INSTITUTIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL WHOLE SLIDE IMAGING FOR PHARMACEUTICAL RESEARCH AND CONTRACT RESEARCH ORGANIZATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. GLOBAL WHOLE SLIDE IMAGING FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 16. GLOBAL WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 19. NORTH AMERICAN WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY APPLICATION,2022-2030 ($ MILLION)
  • 20. NORTH AMERICAN WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 21. EUROPEAN WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 22. EUROPEAN WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 23. EUROPEAN WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY APPLICATION , 2022-2030 ($ MILLION) EUROPEAN WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 24. ASIA- PACIFIC WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 25. ASIA- PACIFIC WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 26. ASIA- PACIFIC WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY APPLICATION , 2022-2030 ($ MILLION)
  • 27. ASIA- PACIFIC WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY APPLICATION ,2022-2030 ($ MILLION)
  • 31. REST OF THE WORLD WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL WHOLE SLIDE IMAGING MARKET SHARE BY TECHNOLOGY, 2022 VS 2030 (%)
  • 2. GLOBAL WHOLE SLIDE IMAGING BY SCANNERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL WHOLE SLIDE IMAGING BY IT INFRASTRUCTURE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL WHOLE SLIDE IMAGING BY VIEWERIMAGE MANAGEMENT SYSTEM MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL WHOLE SLIDE IMAGING MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 6. GLOBAL WHOLE SLIDE IMAGING IN TELEPATHOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL WHOLE SLIDE IMAGING IN CYTOPATHOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL WHOLE SLIDE IMAGING IN IMMUNOHISTOCHEMISTRY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL WHOLE SLIDE IMAGING IN HEMATOPATHOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL WHOLE SLIDE IMAGING IN OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL WHOLE SLIDE IMAGING MARKET SHARE BY END USER, 2022 VS 2030 (%)
  • 12. GLOBAL WHOLE SLIDE IMAGING FOR ACADEMIC INSTITUTE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL WHOLE SLIDE IMAGING FOR HOSPITALS AND HEALTHCARE INSTITUTIONS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL WHOLE SLIDE IMAGING FOR PHARMACEUTICAL RESEARCH AND CONTRACT RESEARCH ORGANIZATIONS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL WHOLE SLIDE IMAGING FOR OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 16. GLOBAL WHOLE SLIDE IMAGING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 17. US WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. CANADA WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. UK WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. FRANCE WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. GERMANY WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. ITALY WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. SPAIN WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. REST OF EUROPE WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. INDIA WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. CHINA WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. JAPAN WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. SOUTH KOREA WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. REST OF ASIA-PACIFIC WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)